Physician profile
Stephen Baker
NPI 1013011303
$5,630.61
in general payments reported to CMS, 2019-2025
36 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $204 · 2021: $334 · 2022: $975 · 2023: $1,696 · 2024: $992 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,000.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $496.41 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $438.37 | 2022-2025 | Azure Xt Dr Mri Surescan, Linq II, Micra |
| E.R. Squibb & Sons, L.L.C. | $436.39 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.47 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $335.56 | 2021-2025 | Verquvo |
| Abiomed | $335.53 | 2023-2025 | Impella |
| Boston Scientific Corporation | $324.62 | 2023-2024 | Synergy, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $304.24 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $274.19 | 2019-2024 | Xarelto |
| Abbott Laboratories | $259.88 | 2021-2025 | Cardiomems |
| Inspire Medical Systems, INC. | $251.35 | 2023-2025 | Inspire |
| Cvrx, INC. | $240.26 | 2024-2025 | Barostim Neo System |
| Irhythm Technologies, INC. | $134.72 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.10 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $125.71 | 2022-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $125.07 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $115.97 | 2022-2024 | Assure Wcd |
| Acist Medical Systems, INC. | $115.96 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $100.92 | 2020-2025 | Farxiga |
| Inari Medical, INC. | $89.45 | 2022 | |
| Amgen INC. | $88.20 | 2023-2025 | Repatha, Repatha |
| Baxter Healthcare | $84.48 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $75.76 | 2021 | |
| Novo Nordisk INC | $62.67 | 2019-2024 | Ozempic |
| Kiniksa Pharmaceuticals, Ltd. | $59.30 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $49.93 | 2023-2024 | |
| Esperion Therapeutics, INC. | $47.62 | 2020-2023 | Nexletol |
| Daiichi Sankyo INC. | $29.45 | 2024 | Injectafer |
| Sumitomo Pharma America, INC. | $27.46 | 2025 | Gemtesa |
| Biotronik INC. | $24.00 | 2022 | |
| Itamar Medical INC | $20.12 | 2023 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $16.69 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $15.74 | 2024 | Arcalyst |
| Astellas Pharma US INC | $15.05 | 2020 | |
| Cardiva Medical, INC. | $14.83 | 2022 | |
| Kerecis Limited | $14.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.